Package 68180-320-02

{"route": ["ORAL"], "spl_id": "dbdd8397-08cd-4e0a-b545-601a288c195c", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["1af14d2e-c64d-44b7-a402-8869e8e30661"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-320-02)", "package_ndc": "68180-320-02", "marketing_start_date": "20170614"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-320-06)", "package_ndc": "68180-320-06", "marketing_start_date": "20170614"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-320-09)", "package_ndc": "68180-320-09", "marketing_start_date": "20170614"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "68180-320_dbdd8397-08cd-4e0a-b545-601a288c195c", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68180-320", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20170614", "listing_expiration_date": "20261231"}